Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • honey
    Senior Member
    • Feb 2010
    • 151

    #1

    control and test in DE in RNA-seq

    I have been analyzing the mRNA-seq data using Cuffdiff and has two questions:

    1. In case of Differential expression analyis between a control vs test sample, ln fold change is represented as Value2/ Value1 as per the manual of Cufflink. I was wondering Value 1 should be control while Value 2 should be test sample.
    From Cufflink manual:
    FPKMx 8.01089 FPKM of the gene in sample x
    FPKMy 8.551545 FPKM of the gene in sample y
    ln(FPKMy/FPKMx) 0.06531 The natural log of the fold change y/x

    2. In typical control vs test sample based on Hg19 reference annotation- I get around 36K transcripts (total including no test and test OK) that seems to be little less as expected. Does it seem to be right number?

    3. When I combine/ filter combined GTF file with any of isoform.exp file I get
    RIC8A chr11:202907-236320 OK chr11 207163 208938 exon 1
    RIC8A chr11:202907-236320 OK chr11 209271 209318 exon 2
    RIC8A chr11:202907-236320 OK chr11 209407 210000 exon 5

    Here the combined GTF provide a location (in red) Chr11 202907-236320 while cufdiff provide exon spanning 207163 208938. What is the first location refer to It is referring to neither gene location nor longest transcript. Any suggestion please.
    Thanks
    Last edited by honey; 04-18-2011, 09:56 PM.
  • honey
    Senior Member
    • Feb 2010
    • 151

    #2
    Question

    Any suggestion please.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    38 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    44 views
    0 reactions
    Last Post SEQadmin2  
    Working...